Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination Treatment With Remdesivir and Ivermectin Exerts Highly Synergistic and Potent Antiviral Activity Against Murine Coronavirus Infection
Yu Ling Tan, Kevin S. W. Tan, Justin Jang Hann Chu, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

The Broad-Spectrum Antiviral Potential of the Amphibian Peptide AR-23
Annalisa Chianese, Carla Zannella, Alessandra Monti, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 883-883
Open Access | Times Cited: 39
Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity
Ashley Jia Wen Yip, Zheng Yao Low, Vincent Chow, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1345-1345
Open Access | Times Cited: 38
Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices
Tushar Saha, Miguel E. Quiñones‐Mateu, Shyamal C. Das
International Journal of Pharmaceutics (2022) Vol. 624, pp. 122042-122042
Open Access | Times Cited: 26
Drug safety of frequently used drugs and substances for self-medication in COVID-19
Daniela Baracaldo-Santamaría, Santiago Pabón-Londoño, Luis Carlos Rojas-Rodríguez
Therapeutic Advances in Drug Safety (2022) Vol. 13
Open Access | Times Cited: 24
Recent advances in small-molecular therapeutics for COVID-19
Lei Zhong, Zhipeng Zhao, Xuerun Peng, et al.
Precision Clinical Medicine (2022) Vol. 5, Iss. 4
Open Access | Times Cited: 21
The Impacts of COVID-19 on Musculoskeletal Health
Olatundun D. Awosanya, Ushashi C. Dadwal, Erik A. Imel, et al.
Current Osteoporosis Reports (2022) Vol. 20, Iss. 4, pp. 213-225
Open Access | Times Cited: 20
Mapping Scientific Productivity Trends and Hotspots in Remdesivir Research Publications: A Bibliometric Study from 2016 to 2021
Ropo Ebenezer Ogunsakin, Oluwakemi Ebenezer, Maryam Amra Jordaan, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8845-8845
Open Access | Times Cited: 17
Inhaled Dry Powder of Antiviral Agents: A Promising Approach to Treating Respiratory Viral Pathogens
Tushar Saha, Zia Uddin Masum, Anik Naha Biswas, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 252-252
Open Access
Unlocking the potential of remdesivir: innovative approaches to drug delivery
Maie S. Taha, Ahsan R. Akram, Ghada A. Abdelbary
Drug Delivery and Translational Research (2025)
Open Access
The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs
André Schreiber, Benjamin Ambrosy, Oliver Planz, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1776-1776
Open Access | Times Cited: 15
Synthesis of Potential Antiviral Agents for SARS-CoV-2 Using Molecular Hybridization Approach
Kailey A. Wyman, Adel S. Girgis, Pragnakiran S. Surapaneni, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 5923-5923
Open Access | Times Cited: 15
Strictinin, a Major Ingredient in Yunnan Kucha Tea Possessing Inhibitory Activity on the Infection of Mouse Hepatitis Virus to Mouse L Cells
Erh-Chuang Tu, Wei‐Li Hsu, Jason T. C. Tzen
Molecules (2023) Vol. 28, Iss. 3, pp. 1080-1080
Open Access | Times Cited: 7
Ivermectin ameliorates acute myocarditis via the inhibition of importin-mediated nuclear translocation of NF-κB/p65
Xu Gao, Yunling Xuan, Zhou Zhou, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112073-112073
Closed Access | Times Cited: 2
Dengue virus: pathogenesis and potential small molecule antivirals
Navya Chauhan, Kishan Kumar Gaur, Tejeswara Rao Asuru, et al.
Bioscience Reports (2024) Vol. 44, Iss. 8
Open Access | Times Cited: 2
Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants
Océane Delandre, Mathieu Gendrot, Priscilla Jardot, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 445-445
Open Access | Times Cited: 11
Effect of remdesivir on mortality rate and clinical status of COVID-19 patients: a systematic review with meta-analysis
Carmine Sellitto, Graziamaria Corbi, Nicola Bertini, et al.
Journal of Chemotherapy (2022) Vol. 35, Iss. 5, pp. 383-396
Closed Access | Times Cited: 8
Bioassay-Guided Fractionation of Erythrostemon yucatanensis (Greenm.) Gagnon & GP Lewis Components with Anti-hemagglutinin Binding Activity against Influenza A/H1N1 Virus
Tania Ortiz-López, Rocı́o Borges-Argáez, Guadalupe Ayora‐Talavera, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5494-5494
Open Access | Times Cited: 7
Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic
Manuel Castillejos‐López, Luz María Torres‐Espíndola, Juan Carlos Huerta­-Cruz, et al.
Life (2022) Vol. 12, Iss. 9, pp. 1384-1384
Open Access | Times Cited: 7
Drug repurposing of pyrazolotriazine derivatives as potential anti-SARS-CoV-2 agents: in vitro and in silico studies
Khulood H. Oudah, Mazin A. A. Najm, Reham F. Barghash, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Favipiravir and ivermectin show in vitro synergistic antiviral activity against SARS-CoV-2
Kunlakanya Jitobaom, Chompunuch Boonarkart, Suwimon Manopwisedjaroen, et al.
Acta Virologica (2023) Vol. 67
Open Access | Times Cited: 3
Synergistic In Vitro Antiviral Effect of Combinations of Ivermectin, Essential Oils, and 18-(Phthalimid-2-yl)ferruginol against Arboviruses and Herpesvirus
Liliana Betancur‐Galvis, Orlando José Jimenez-Jarava, Fatima Rivas, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1602-1602
Open Access | Times Cited: 2
Characterization of a unique catechol-O-methyltransferase as a molecular drug target in parasitic filarial nematodes
Md. Mukthar Mia, I. M. Allaie, Xuejin Zhang, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 8, pp. e0012473-e0012473
Open Access
Repurposing of Doxycycline to Attenuate Influenza Virus Pathogenesis Via Inhibition of Matrix Metalloproteinases in Neutrophils
Teluguakula Narasaraju, Charlene Hui Hua Fong, Sunil K. Lal, et al.
(2023), pp. 529-542
Closed Access | Times Cited: 1
Antiviral Uses of Ivermectin
Shabnam Kawoosa, Rabiah Bashir, Sheeba Nazir, et al.
(2023), pp. 231-246
Closed Access | Times Cited: 1
Synergistic in vitro Antiviral Effect of Combinations of Ivermectin, Essential Oils and 18-(Phthalimid-2-yl)ferruginol Against Arboviruses and Herpesvirus
Liliana Betancur‐Galvis, Orlando José Jimenez-Jarava, Fatima Rivas, et al.
(2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top